Commodore Capital LP

Holdings History for Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO)

Symbol: MREO on Nasdaq
Investment type: Equity / Ordinary Shares, par value GBP 0.003 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2022		-0.49%	$0	0	-1,954,970	-100%	$0.39	Q2 2022
31 Mar 2022	0.49%	0%	$2,190,000	1,954,970	0		$1.12	Q1 2022
31 Dec 2021	0.72%	-0.01%	$3,128,000	1,954,970	-17,988	-0.91%	$1.60	Q4 2021
30 Sep 2021	1.3%	-0.06%	$4,775,000	1,972,958	-86,771	-4.2%	$2.42	Q3 2021
30 Jun 2021	2.3%	+0.01%	$6,529,000	2,059,729	+10,972	+0.54%	$3.17	Q2 2021
31 Mar 2021	2.8%	+0.26%	$6,904,000	2,048,757	+194,479	+10%	$3.37	Q1 2021
31 Dec 2020	3.6%	0%	$6,638,000	1,854,278	0		$3.58	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.